The transgelin promoter drives the expression of the rtTA transactivator in this transgene. When doxycycline is present, the transactivator binds to the tet responsive element (tetO) to direct cre expression. The reverse tetracycline-controlled transactivator was modified to be inducible by lower concentrations of doxycycline with greater control of basal expression.